成人 AML 患者接受强度较低治疗的遗传风险分类：2024 年 ELN 建议。
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations.
机构信息
Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany.
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
出版信息
Blood. 2024 Nov 21;144(21):2169-2173. doi: 10.1182/blood.2024025409.
PMID:39133932
Abstract
The European LeukemiaNet (ELN) genetic risk classifications were developed based on data from younger adults receiving intensive chemotherapy. Emerging analyses from patients receiving less-intensive therapies prompted a proposal for an ELN genetic risk classification specifically for this patient population.
摘要
欧洲白血病网络（ELN）的遗传风险分类是基于接受强化化疗的年轻成年人的数据制定的。来自接受非强化治疗患者的新分析促使提出了一个专门针对这一患者群体的 ELN 遗传风险分类建议。
Zotero 插件